Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hylenex for Dissolving HA Dermal Fillers
NCT02654522Phase 1Completed
- Sponsor
- Steve Yoelin M.D. Medical Associates
- Start
- Jan 2016
- Primary completion
- Feb 2016
- Modality
- Therapeutic Enzymes
01
Overview
Phase 1, randomised trial of hyaluronidase (2 arms), sponsored by Steve Yoelin M.D. Medical Associates. Primary endpoint: Cutaneous Augmentation Grading Scale. Started Jan 2016; status: completed.
02
Drugs
hyaluronidase
Beyond the preview
Go deeper on NCT02654522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654522.